Publications by authors named "Y I Cheng"

The article explores celery-derived extracellular vesicles (CDEVs), characterized by high cellular uptake, low immunogenicity, and high stability, as a therapeutic strategy for antitumor nanomedicines. The methods employed in this study include cell experiments such as co-culture, Western Blot, and flow cytometry. experiments were conducted in C57BL/6 tumor-bearing mice subcutaneously injected with Lewis lung carcinoma (LLC) cells.

View Article and Find Full Text PDF

This study aims to determine the changes in the photosynthetic performance of leaves at different leaf positions and their correlation and to screen out the basic tillage methods suitable for improving the yield. The decrease in soil salt content significantly improved the PSII performance index and quantum yield for electron transport of the bottom leaf group, synergistically enhanced the photosynthetic performance of summer maize leaves (especially the bottom leaf group), and enhanced the correlation between the bottom, middle (including the ear leaf), and upper leaf groups. Under subsoiling tillage conditions, the bottom leaves could produce more carbohydrates to meet the normal growth of the root system, promote the photosynthesis of the middle leaf group at the ear position, and increase the nutrient output of the upper leaf group to the female ear in the middle and later stages of maize aging.

View Article and Find Full Text PDF

Low tumor enrichment remains a serious and urgent problem for drug delivery in cancer therapy. Accurate targeting of tumor sites is still a critical aim in cancer therapy. Though there have been a variety of delivery strategies to improve the tumor targeting and enrichment, biological barriers still cause most delivered guests to fail or be excreted before they work.

View Article and Find Full Text PDF

Aberrant responses (e.g., careless responses, miskeyed items, etc.

View Article and Find Full Text PDF

Gut microbiota affect transplantation outcomes; however, the influence of immunosuppression and cell therapy on the gut microbiota in cardiovascular care remains unexplored. We investigated gut microbiota dynamics in a nonhuman primate (NHP) cardiac ischemia/reperfusion model while under immunosuppression and receiving cell therapy with human induced pluripotent stem cell (hiPSC)-derived endothelial cells (EC) and cardiomyocytes (CM). Both immunosuppression and EC/CM co-treatment increased gut microbiota alpha diversity.

View Article and Find Full Text PDF